GF
SLXNW

Gabelli Funds’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Gabelli Funds’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$619 Hold
30,496
– – ﹤0.01% 1263
2025
Q4 		$793 Hold
30,496
– – ﹤0.01% 1244
2025
Q3 		$1.07K Hold
30,496
– – ﹤0.01% 1241
2025
Q2 		$1.25K Hold
30,496
– – ﹤0.01% 1218
2025
Q1 		$2.33K Buy
+30,496
New +$1.86K ﹤0.01% 1083
2024
Q4 		– Sell
-30,496
Closed -$967 – 1114
2024
Q3 		$967 Buy
+30,496
New +$1.77K ﹤0.01% 1091

Other funds holding SLXNW

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return

Gabelli Funds's SLXNW Position: Q1 2026 in Review

Gabelli Funds held its Silexion Therapeutics Warrant (SLXNW) position steady in Q1 2026 at 30,496 shares worth $619. The position accounts for ﹤0.01% of the portfolio, ranked #1263.

Gabelli Funds first reported a position in SLXNW in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.33K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q1 2026.

  • Gabelli Funds held 30,496 shares of Silexion Therapeutics Warrant worth $619 as of Q1 2026.
  • Gabelli Funds left its Silexion Therapeutics Warrant share count unchanged in Q1 2026.
  • Silexion Therapeutics Warrant made up ﹤0.01% of Gabelli Funds's portfolio in Q1 2026, its #1263 holding.
  • Gabelli Funds first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 6 quarters since.
  • Gabelli Funds's Silexion Therapeutics Warrant position peaked at $2.33K in Q1 2025.
  • 19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.